These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1631165)

  • 1. Endosulfine, an endogenous peptidic ligand for the sulfonylurea receptor: purification and partial characterization from ovine brain.
    Virsolvy-Vergine A; Leray H; Kuroki S; Lupo B; Dufour M; Bataille D
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6629-33. PubMed ID: 1631165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endosulfine, endogenous ligand for the sulphonylurea receptor: isolation from porcine brain and partial structural determination of the alpha form.
    Virsolvy-Vergine A; Salazar G; Sillard R; Denoroy L; Mutt V; Bataille D
    Diabetologia; 1996 Feb; 39(2):135-41. PubMed ID: 8635664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the sulfonylurea receptor on beta cell membranes.
    Gaines KL; Hamilton S; Boyd AE
    J Biol Chem; 1988 Feb; 263(6):2589-92. PubMed ID: 3125168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photoaffinity labeling and partial purification of the beta cell sulfonylurea receptor using a novel, biologically active glyburide analog.
    Aguilar-Bryan L; Nelson DA; Vu QA; Humphrey MB; Boyd AE
    J Biol Chem; 1990 May; 265(14):8218-24. PubMed ID: 2110566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at beta-cells.
    Kramer W; Müller G; Geisen K
    Horm Metab Res; 1996 Sep; 28(9):464-8. PubMed ID: 8911984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfonylurea receptors, ion channels, and fruit flies.
    Boyd AE
    Diabetes; 1988 Jul; 37(7):847-50. PubMed ID: 2454858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel enhancer of insulinotrophic action by high glucose (JTT-608) stimulates insulin secretion from pancreatic beta-cells via a new cellular mechanism.
    Itabashi N; Okada K; Muto S; Fujita N; Ohta T; Miyazaki Ji ; Asano Y; Saito T
    J Pharmacol Exp Ther; 2001 Jun; 297(3):953-60. PubMed ID: 11356916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of trypsin on ATP-sensitive potassium channel properties and sulfonylurea receptors in the CRI-G1 insulin-secreting cell line.
    Lee K; Ozanne SE; Rowe IC; Hales CN; Ashford ML
    Mol Pharmacol; 1994 Jul; 46(1):176-85. PubMed ID: 8058051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. II. Photoaffinity labeling of a 65 kDa protein by [3H]glimepiride.
    Kramer W; Müller G; Girbig F; Gutjahr U; Kowalewski S; Hartz D; Summ HD
    Biochim Biophys Acta; 1994 May; 1191(2):278-90. PubMed ID: 8172913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of sulfonylurea receptors in isolated human pancreatic islets.
    Giannaccini G; Lupi R; Trincavelli ML; Navalesi R; Betti L; Marchetti P; Lucacchini A; Del Guerra S; Martini C
    J Cell Biochem; 1998 Nov; 71(2):182-8. PubMed ID: 9779817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfonylurea receptor 1 and Kir6.2 expression in the novel human insulin-secreting cell line NES2Y.
    Macfarlane WM; O'Brien RE; Barnes PD; Shepherd RM; Cosgrove KE; Lindley KJ; Aynsley-Green A; James RF; Docherty K; Dunne MJ
    Diabetes; 2000 Jun; 49(6):953-60. PubMed ID: 10866047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. I. Binding characteristics.
    Müller G; Hartz D; Pünter J; Okonomopulos R; Kramer W
    Biochim Biophys Acta; 1994 May; 1191(2):267-77. PubMed ID: 8172912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unresponsiveness to glibenclamide during chronic treatment induced by reduction of ATP-sensitive K+ channel activity.
    Kawaki J; Nagashima K; Tanaka J; Miki T; Miyazaki M; Gonoi T; Mitsuhashi N; Nakajima N; Iwanaga T; Yano H; Seino S
    Diabetes; 1999 Oct; 48(10):2001-6. PubMed ID: 10512365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible involvement of protein phosphorylation in the regulation of the sulphonylurea receptor of a pancreatic beta-cell line, HIT T15.
    Niki I; Ashcroft SJ
    Biochim Biophys Acta; 1991 Dec; 1133(1):95-101. PubMed ID: 1836360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.
    Gribble FM; Tucker SJ; Seino S; Ashcroft FM
    Diabetes; 1998 Sep; 47(9):1412-8. PubMed ID: 9726229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct photoaffinity labeling of the putative sulfonylurea receptor in rat beta-cell tumor membranes by [3H]glibenclamide.
    Kramer W; Oekonomopulos R; Pünter J; Summ HD
    FEBS Lett; 1988 Mar; 229(2):355-9. PubMed ID: 2831099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinity isolation of imidazoline binding proteins from rat brain using 5-amino-efaroxan as a ligand.
    Monks LK; Cosgrove KE; Dunne MJ; Ramsden CA; Morgan NG; Chan SL
    FEBS Lett; 1999 Mar; 447(1):61-4. PubMed ID: 10218583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and significance of sulfonylurea receptors.
    Siconolfi-Baez L; Banerji MA; Lebovitz HE
    Diabetes Care; 1990 Aug; 13 Suppl 3():2-8. PubMed ID: 2209340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An endogenous ligand for the central sulfonylurea receptor.
    Virsolvy-Vergine A; Brück M; Dufour M; Cauvin A; Lupo B; Bataille D
    FEBS Lett; 1988 Dec; 242(1):65-9. PubMed ID: 3144466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The beta-cell glibenclamide receptor is an ADP-binding protein.
    Niki I; Nicks JL; Ashcroft SJ
    Biochem J; 1990 Jun; 268(3):713-8. PubMed ID: 2114099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.